Marc Feldmann serves as Executive at 180 Life Sciences Corp., where they oversee executive responsibilities. Since joining the company, Marc Feldmann has executed 6 insider transactions totaling $208.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 28, 2023 involved receiving (via award) 135,377 shares valued at $0.
Marc Feldmann currently holds 250,874 shares of 180 Life Sciences Corp. (ATNF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Feldmann has been a net buyer of ATNF stock. They have purchased $203.5K and sold $4.8K worth of shares.
Marc Feldmann's most recent insider trade was on Dec 28, 2023, when they sold 135,377 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.19 |
| Discretionary |
| Dec 9, 2021 | ATNF | $203.5K | Purchase | 50,000 | $4.07 | Discretionary |
| Dec 8, 2021 | ATNF | $21.9K | Award | 5,536 | $3.95 | Discretionary |
| Sep 30, 2021 | ATNF | $819.8K | Award | 136,636 | $6.00 | Discretionary |
| Apr 7, 2021 | ATNF | $128.4K | Award | 20,910 | $6.14 | Discretionary |